IVIg protects the 3xTg-AD mouse model of Alzheimer’s disease from memory deficit and Aβ pathology

BACKGROUND: Intravenous immunoglobulin (IVIg) is currently in clinical study for Alzheimer’s disease (AD). However, preclinical investigations are required to better understand AD-relevant outcomes of IVIg treatment and develop replacement therapies in case of unsustainable supply. METHODS: We inves...

Descripción completa

Detalles Bibliográficos
Autores principales: St-Amour, Isabelle, Paré, Isabelle, Tremblay, Cyntia, Coulombe, Katherine, Bazin, Renée, Calon, Frédéric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997966/
https://www.ncbi.nlm.nih.gov/pubmed/24655894
http://dx.doi.org/10.1186/1742-2094-11-54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997966/
https://www.ncbi.nlm.nih.gov/pubmed/24655894
http://dx.doi.org/10.1186/1742-2094-11-54

Ejemplares similares